Laughon Matthew, Bose Carl, Allred Elizabeth, O'Shea T Michael, Van Marter Linda J, Bednarek Francis, Leviton Alan
School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pediatrics. 2007 Feb;119(2):273-80. doi: 10.1542/peds.2006-1138.
The goals were to identify the blood pressures of extremely low gestational age newborns that prompt intervention, to identify other infant characteristics associated with receipt of therapies intended to increase blood pressure, and to assess the interinstitutional variability in the use of these therapies.
The cohort included 1507 extremely low gestational age newborns born at 23 weeks to 27 weeks of gestation, at 14 institutions, between March 2002 and August 2004; 1387 survived the first postnatal week. Blood pressures were measured as clinically indicated. Interventions were grouped as any treatment (ie, vasopressor and/or fluid boluses of >10 mL/kg) and vasopressor treatment, and logistic regression analyses were performed.
At each gestational age, the lowest mean arterial pressures in treated and untreated infants tended to increase with advancing postnatal age. Infants who received any therapy tended to have lower mean arterial pressures than infants who did not, but uniform thresholds for treatment were not apparent. The proportion of infants receiving any treatment decreased with increasing gestational age from 93% at 23 weeks to 73% at 27 weeks. Treatment nearly always began during the first 24 hours of life. Lower gestational age, lower birth weight, male gender, and higher Score for Neonatal Acute Physiology-II values were associated with any treatment and vasopressor treatment. Institutions varied greatly in their tendency to offer any treatment and vasopressor treatment. Neither the lowest mean arterial pressure on the day of treatment nor other characteristics of the infants accounted for center differences in treatment.
Blood pressure in extremely premature infants not treated for hypotension increased directly with both increasing gestational age and postnatal age. The decision to provide treatment was associated more strongly with the center where care was provided than with infant attributes.
目标是确定促使进行干预的极低胎龄新生儿的血压,确定与接受旨在升高血压的治疗相关的其他婴儿特征,并评估这些治疗使用方面的机构间差异。
该队列包括2002年3月至2004年8月期间在14家机构出生的1507例孕23至27周的极低胎龄新生儿;1387例在出生后第一周存活。根据临床指征测量血压。干预措施分为任何治疗(即血管升压药和/或大于10 mL/kg的液体推注)和血管升压药治疗,并进行逻辑回归分析。
在每个胎龄,接受治疗和未接受治疗的婴儿的最低平均动脉压往往随着出生后年龄的增加而升高。接受任何治疗的婴儿的平均动脉压往往低于未接受治疗的婴儿,但未发现统一的治疗阈值。接受任何治疗的婴儿比例随着胎龄的增加而降低,从23周时的93%降至27周时的73%。治疗几乎总是在出生后24小时内开始。较低的胎龄、较低的出生体重、男性性别以及较高的新生儿急性生理学-II评分值与任何治疗和血管升压药治疗相关。各机构在提供任何治疗和血管升压药治疗的倾向方面差异很大。治疗当天的最低平均动脉压或婴儿的其他特征均不能解释各中心在治疗方面的差异。
未因低血压接受治疗的极早产儿的血压随胎龄和出生后年龄的增加而直接升高。提供治疗的决定与提供护理的中心的关联比与婴儿属性的关联更强。